TrademarkDir
VX
LIVE

Serial Number

97228935

Owner

Harvard MedTech, LLC

Attorney

Stephanie Matthews

First Use Date

Feb 5, 2019

Filing Date

Jan 20, 2022

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

VX Trademark

Serial Number: 97228935 • Registration: 7452598

VX is a trademark filed by Harvard MedTech, LLC on January 20, 2022. The trademark is classified under Class 9 (Computers & Electronics). The application is currently registered and active.

Owner Contact Info

Harvard MedTech, LLC (10 trademarks)

6280 S. Valley View Blvd., Ste. 412
Las Vegas, NV 89118

Entity Type: 16

Trademark Details

Filing Date

January 20, 2022

Registration Date

July 23, 2024

First Use Anywhere

February 5, 2019

First Use in Commerce

February 5, 2019

Published for Opposition

February 6, 2024

Goods & Services

Recorded virtual reality software for treating pain, anxiety, stress and depression, preloaded in wireless-enabled Virtual Reality headsets using telecommunication and global computer networks for patients' use in-home, via mobile devices and in health care facilities

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 23, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 23, 2024 R.PR
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Jun 16, 2024 ETOP
EXTENSION OF TIME TO OPPOSE RECEIVED
Mar 4, 2024 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 6, 2024 NPUB
PUBLISHED FOR OPPOSITION
Feb 6, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 17, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 2, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 27, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 27, 2023 CRFA
ASSIGNED TO LIE
Dec 27, 2023 ALIE
NOTICE OF REVIVAL - E-MAILED
Aug 2, 2023 NREV
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 1, 2023 TROA
PETITION TO REVIVE-GRANTED
Aug 1, 2023 PETG
TEAS PETITION TO REVIVE RECEIVED
Aug 1, 2023 PROA
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Jun 2, 2023 MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Jun 2, 2023 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jun 2, 2023 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 2, 2022 GNRN
NON-FINAL ACTION E-MAILED
Nov 2, 2022 GNRT
NON-FINAL ACTION WRITTEN
Nov 2, 2022 CNRT
ASSIGNED TO EXAMINER
Oct 31, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 25, 2022 NWOS
NEW APPLICATION ENTERED
Jan 24, 2022 NWAP

Related Trademarks

More from this Owner

VX THERAPY

VX THERAPY

VX THERAPY

VX THERAPY

VX THERAPY

VX THERAPY

VXE2

VXE2

VXE2

VXE2

VXIO

VXIO